RINGER SOLUTION DAB 7 Plastic, Hypotonic dehydration treatment

Ringer's Solution DAB 7 Infusion Solution. Indications: Fluid and electrolyte replacement in cases of hypochloremic alkalosis or chloride loss, as short-term intravascular volume replacement, isotonic dehydration, hypotonic dehydration, as a carrier solution for compatible electrolyte concentrates and medications.

For risks and side effects, read the package insert and consult your doctor or pharmacist.


PACKAGE LEAFLET: INFORMATION FOR THE USER

Ringer's Solution DAB 7 Infusion Solution.

This package insert contains:

1. WHAT IS RINGER'S SOLUTION DAB 7 AND WHAT IS IT USED FOR?
2. WHAT SHOULD YOU CONSIDER BEFORE USING RINGER'S SOLUTION DAB 7?
3. HOW SHOULD RINGER SOLUTION DAB 7 BE USED?
4. WHAT SIDE EFFECTS ARE POSSIBLE?
5. HOW SHOULD RINGER SOLUTION DAB 7 BE STORED?
6. MORE INFORMATION

1. WHAT IS RINGER'S SOLUTION DAB 7 AND WHAT IS IT USED FOR?

Substance or indication group or mode of action:
Electrolyte solution. 1 ml contains: 0.147 mmol Na+, 4 pmol K+, 2.25 pmol Ca++, 0.156 mmol Cl-.

Indications:

• Fluid and electrolyte replacement in cases of hypochloremic alkalosis or chloride losses,
• as short-term intravascular volume replacement,
• isotonic dehydration,
• hypotonic dehydration,
• as a carrier solution for compatible electrolyte concentrates and medications.

2. WHAT SHOULD YOU CONSIDER BEFORE USING RINGER'S SOLUTION DAB 7?

Contraindications:
Absolute contraindication:

• Overhydration conditions (hyperhydration conditions).

Relative contraindications:

• increased potassium content in the blood (hyperkalemia).
• increased sodium content in the blood (hypernatremia).
• increased chloride content of the blood (hyperchloremia).
• Conditions that require restrictive sodium intake (such as heart failure, generalized edema, pulmonary edema, hypertension, eclampsia, severe renal insufficiency).

Caution is advised in patients with renal insufficiency who are prone to elevated blood potassium levels (hyperkalemia).

Precautions for use and warnings:
Electrolyte and fluid status checks are required. When treating hypertonic dehydration, excessively rapid infusion must be avoided at all costs (caution: increase in plasma osmolarity and plasma sodium concentration).

Interactions with other medicinal products:
Interactions are not known. For information on incompatibility, see ###Additional information for healthcare professionals###.

Pregnancy and breastfeeding:
There are no concerns about use during pregnancy and breastfeeding.

3. HOW SHOULD RINGER'S SOLUTION DAB 7 BE USED?

Dosage instructions:
The dosage depends on the fluid and electrolyte requirements.

Maximum infusion rate:
The maximum infusion rate depends on the patient's clinical condition.

Maximum daily dose:
The maximum daily dose depends on the patient's fluid and electrolyte requirements. A fluid intake of 40 ml/kg body weight per day should not be exceeded in adults.

Method of administration:
For intravenous infusion.

Overdose:
Overdose can lead to overhydration, electrolyte imbalance, hyperosmolarity, and the induction of an acidotic metabolic state. Treatment: Interruption of the solution supply, accelerated elimination via the kidneys, and reduced supply of the corresponding electrolytes.

If you have any questions regarding use, consult your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS:

No side effects are to be expected when used as directed.

Reporting of side effects
:
If you notice any side effects, contact your doctor or pharmacist. This also applies to side effects not listed in this package leaflet. You can also report side effects directly to the Federal Institute for Drugs and Medical Devices, Pharmacovigilance Department, Kurt-Georg-Kiesinger-Allee 3, D-53175 Bonn, website: www.bfarm.de. By reporting side effects, you can help provide more information on the safety of this medicine.

Additional information for healthcare professionals:
Reporting suspected side effects:
Reporting suspected side effects after authorization is very important. It allows for continuous monitoring of the benefit-risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions to the Federal Institute for Drugs and Medical Devices, Pharmacovigilance Department, Kurt-Georg-Kiesinger Allee 3, D-53175 Bonn

5. HOW SHOULD RINGER'S SOLUTION DAB 7 BE STORED?

Do not use after the expiry date printed on the container and outer packaging! Keep out of the sight and reach of children! Use immediately after opening! Use only clear solutions in undamaged containers! Never dispose of medicines via wastewater (e.g., not down the toilet or sink). Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment. Further information can be found at www.bfarm.de/arzneimittelentsorgung.

6. FURTHER INFORMATION

Composition:
1000 ml of infusion solution contains: Active ingredients: Sodium chloride 8.60 g, Potassium chloride 0.30 g, Calcium chloride dihydrate 0.33 g. Other ingredients: Water for injections. Electrolytes: Na+ 147 mmol/l, K+ 4 mmol/l, Ca++ 2.25 mmol/l, Cl- 156 mmol/l. Theoretical osmolarity: 309 mOsm/l. pH: 5.0 - 7.5.

Dosage form:
Dosage form: Solution for infusion. Contents of one plastic bottle: 250 ml, 500 ml, 1000 ml.

Pharmaceutical entrepreneur/manufacturer:
Serag-Wiessner GmbH & Co. KG
Zum Kugelfang 8 - 12
95119 Naila


This package leaflet was last revised in October 2024.

Source: Information from the package leaflet.
Version: 08/2025

Areas of application: Fluid and electrolyte substitution in cases of hypochloremic alkalosis or chloride losses, as short-term intravascular volume replacement, isotonic dehydration, hypotonic dehydration, as a carrier solution for compatible electrolyte concentrates and medications.

Hypotonic dehydration treatment, RINGER SOLUTION DAB 7 Plastic